LSD and DOB: interaction with 5‐HT2A receptors to inhibit NMDA receptor‐mediated transmission in the rat prefrontal cortex
Authors:
- 1 September 1999
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 11 (9) , 3064-3072
Abstract
Both the phenethylamine hallucinogen (–)‐1‐2,5‐dimethoxy‐4‐bromophenyl‐2‐aminopropane (DOB), a selective serotonin 5‐HT2A,2C receptor agonist, and the indoleamine hallucinogen d‐lysergic acid diethylamide (LSD, which binds to 5‐HT1A, 1B, 1D, 1E, 1F, 2A, 2C, 5, 6, 7, dopamine D1 and D2, and α1 and α2 adrenergic receptors), but not their non‐hallucinogenic congeners, inhibited N‐methyl‐d‐aspartate (NMDA)‐induced inward current and NMDA receptor‐mediated synaptic responses evoked by electrical stimulation of the forceps minor in pyramidal cells of the prefrontal cortical slices. The inhibitory effect of hallucinogens was mimicked by 5‐HT in the presence of selective 5‐HT1A and 5‐HT3 receptor antagonists. The inhibitory action of DOB, LSD and 5‐HT on the NMDA transmission was blocked by the 5‐HT2A receptor antagonists r‐(+)‐α‐(2,3‐dimethoxyphenil)‐1‐[4‐fluorophenylethyl]‐4‐piperidinemethanol (M100907) and ketanserin. However, at low concentrations, when both LSD and DOB by themselves only partially depressed the NMDA response, they blocked the inhibitory effect of 5‐HT, suggesting a partial agonist action. Whereas N‐(4‐aminobutyl)‐5‐chloro‐2‐naphthalenesulphonamide (W‐7, a calmodulin antagonist) and N‐[2‐[[[3‐(4′‐chlorophenyl)‐ 2‐propenyl]methylamino]methyl]phenyl]‐N‐(2‐hydroxyethyl)‐4′‐methoxy‐benzenesulphonamide phosphate (KN‐93, a Ca2+/CaM‐KII inhibitor), but not the negative control 2‐[N‐4′methoxybenzenesulphonyl]amino‐N‐(4′‐chlorophenyl)‐2‐propenyl‐N‐methylbenzylamine phosphate (KN‐92), blocked the inhibitory action of LSD and DOB, the selective protein kinase C inhibitor chelerythrine was without any effect. We conclude that phenethylamine and indoleamine hallucinogens may exert their hallucinogenic effect by interacting with 5‐HT2A receptors via a Ca2+/CaM‐KII‐dependent signal transduction pathway as partial agonists and modulating the NMDA receptors‐mediated sensory, perceptual, affective and cognitive processes.Keywords
This publication has 40 references indexed in Scilit:
- M100907 and Clozapine, but not Haloperidol or Raclopride, Prevent Phencyclidine-Induced Blockade of NMDA Responses in Pyramidal Neurons of the Rat Medial Prefrontal Cortical SliceNeuropsychopharmacology, 1998
- M100907, A Selective 5-HT2A Receptor Antagonist and a Potential Antipsychotic Drug, Facilitates N-Methyl-D-Aspartate-Receptor Mediated Neurotransmission in the Rat Medial Prefrontal Cortical Neurons In VitroNeuropsychopharmacology, 1998
- The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranesEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- GABAB receptor antagonists: from synthesis to therapeutic applicationsTrends in Pharmacological Sciences, 1993
- Do NMDA receptors have a critical function in visual cortical plasticity?Trends in Neurosciences, 1993
- The newly synthesized selective Ca2+calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cellsBiochemical and Biophysical Research Communications, 1991
- Chelerythrine is a potent and specific inhibitor of protein kinase CBiochemical and Biophysical Research Communications, 1990
- Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agentsLife Sciences, 1984
- Structure-Activity Relationships of Phenethylamine HallucinogensJournal of Pharmaceutical Sciences, 1981
- Effects of lisuride and LSD on cerebral monoamine systems and hallucinosisNature, 1978